Mory Keita
Overview
Explore the profile of Mory Keita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kapaya F, Keita M, Sodjinou V, Nanyunja M, Mpairwe A, Daniel E, et al.
BMJ Glob Health
. 2025 Jan;
10(1).
PMID: 39848635
High-burden cholera outbreaks, spreading beyond the traditional cholera-endemic countries, have been reported since 2021 in the WHO African region. Member states in the region have committed to the global goal...
2.
Noufack G, Bissengue P, Zobanga J, Malingao J, Keita M, Razaiarimanga M, et al.
Vaccines (Basel)
. 2025 Jan;
12(12).
PMID: 39772084
: Yellow fever (YF) outbreaks continue to affect populations that are not reached by routine immunization services, such as workers at a high risk of occupational exposure to YF. In...
3.
Otieno J, Ruis C, Onoja A, Kuppalli K, Hoxha A, Nitsche A, et al.
Nat Med
. 2024 Oct;
31(1):342-350.
PMID: 39442559
Monkeypox virus (MPXV) is endemic in western and Central Africa, and in May 2022, a clade IIb lineage (B.1) caused a global outbreak outside Africa, resulting in its detection in...
4.
Hart W, Buckingham J, Keita M, Ahuka-Mundeke S, Maini P, Polonsky J, et al.
Sci Adv
. 2024 Jul;
10(27):eado7576.
PMID: 38959306
Following the apparent final case in an Ebola virus disease (EVD) outbreak, the decision to declare the outbreak over must balance societal benefits of relaxing interventions against the risk of...
5.
Keita M, Boland S, Okeibunor J, Chamla D, Gueye A, Moeti M
Lancet
. 2024 Mar;
403(10444):2573-2575.
PMID: 38527478
No abstract available.
6.
Keita M, Cherif I, Polonsky J, Boland S, Kandako Y, Cherif M, et al.
J Epidemiol Glob Health
. 2024 Feb;
14(3):699-709.
PMID: 38372893
Background: In 2021, an Ebola virus disease (EVD) outbreak was declared in Guinea, linked to persistent virus from the 2014-2016 West Africa Epidemic. This paper analyzes factors associated with contact...
7.
Keita M, Polonsky J, Ahuka-Mundeke S, Ilumbulumbu M, Dakissaga A, Boiro H, et al.
BMJ Glob Health
. 2023 Jun;
8(6).
PMID: 37263672
Introduction: Despite tremendous progress in the development of diagnostics, vaccines and therapeutics for Ebola virus disease (EVD), challenges remain in the implementation of holistic strategies to rapidly curtail outbreaks. We...
8.
Cherif M, Keita M, Dahal P, Guilavogui T, Beavogui A, Diassy L, et al.
Int Health
. 2023 May;
15(5):490-504.
PMID: 37232124
Neglected tropical diseases (NTDs) predominantly affect vulnerable and marginalized populations in tropical and subtropical areas and globally affect more than one billion people. In Guinea, the burden of NTDs is...
9.
Koya S, Abdalla S, Kodama C, Keita M, Abubakar A
J Epidemiol Glob Health
. 2023 Feb;
13(1):105-114.
PMID: 36757670
Background And Objective: World Health Organization Eastern Mediterranean Region (WHO EMR) has 40% people in the world in need of humanitarian assistance. This systematic review explores selected vector-borne and zoonotic...
10.
Keita M, Talisuna A, Chamla D, Burmen B, Cherif M, Polonsky J, et al.
BMJ Glob Health
. 2023 Jan;
8(1).
PMID: 36599498
The 2014-2016 West Africa Ebola Virus Disease (EVD) Epidemic devastated Guinea's health system and constituted a public health emergency of international concern. Following the crisis, Guinea invested in the establishment...